The DOI matches its Crossref record; 71 of the 72 references it cites were found in a registry or an index.
N -acetylcysteine for antioxidant therapy: pharmacology and clinical utility
Abstract
BACKGROUND: Glutathione is an endogenous antioxidant and has a ubiquitous role in many of the body's defences. Treatment with N-acetylcysteine (NAC) has been shown to increase levels of glutathione. NAC has been proposed as a treatment for several illnesses. OBJECTIVES: The efficacy and tolerability of NAC was examined across a range of conditions to evaluate the evidence supporting the use of NAC for each indication. METHODS: A literature search was conducted using PubMed. Information was also collected from other online sources including the websites of the Therapeutic Goods Administration of Australia and the FDA. RESULTS: Reports ranged from case studies to clinical trials. There is strong evidence to support the use of NAC for the treatment of paracetamol overdose and emerging evidence suggesting it has utility in psychiatric disorders, particularly schizophrenia and bipolar disorder. NAC is safe and well tolerated when administered orally but has documented risks with intravenous administration.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“NAC is well tolerated, with a side-effect profile that does not differ significantly from placebo when administered orally at doses up to 3 g/day.3”
From N-acetylcysteine for therapy-resistant tobacco use disorder: a pilot study (2015) · cites this paper as [3]
Citations
Cites
The Neural Basis of Addiction: A Pathology of Motivation and Choice
Kalivas, P. W., & Volkow, N. D. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.8.1403 · Cited by 2,757
Oxidative stress in psychiatric disorders: evidence base and therapeutic implications
Ng, F., Berk, M., Dean, O., & Bush, A. I. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707008401 · Cited by 1,069
Self-citationHigh-Dose Acetylcysteine in Idiopathic Pulmonary Fibrosis
Demedts, M., Behr, J., Buhl, R., Costabel, U., Dekhuijzen, R., Jansen, H. M., MacNee, W., Thomeer, M., Wallaert, B., Laurent, F., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042976 · Cited by 964
Oxidative Stress in Chronic Obstructive Pulmonary Disease
REPINE, J. E., BAST, A., LANKHORST, I., & The Oxidative Stress Study Group (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.156.2.9611013 · Cited by 843
Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse
Baker, D. A., McFarland, K., Lake, R. W., Shen, H., Tang, X.-C., Toda, S., & Kalivas, P. W. (2003) · Nature Neuroscience · doi:10.1038/nn1069 · Cited by 739
Drug Addiction as a Pathology of Staged Neuroplasticity
Kalivas, P. W., & O'Brien, C. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301564 · Cited by 733
N-Acetylcysteine—a safe antidote for cysteine/glutathione deficiency
Atkuri, K. R., Mantovani, J. J., Herzenberg, L. A., & Herzenberg, L. A. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2007.04.005 · Cited by 721 · cited 2×
“The latter is the rate-limiting precursor for the endogenous antioxidant glutathione [16] .”
BackgroundBilici, M., Efe, H., Köroğlu, M. A., Uydu, H. A., Bekaroğlu, M., & Değer, O. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00199-3 · Cited by 718
Intravenous N-acetylcystine: the treatment of choice for paracetamol poisoning.
Prescott, L. F., Illingworth, R. N., Critchley, J. A., Stewart, M. J., Adam, R. D., & Proudfoot, A. T. (1979) · BMJ · doi:10.1136/bmj.2.6198.1097 · Cited by 667
Intravenous N-acetylcysteine: still the treatment of choice for paracetamol poisoning.
Prescott, L. F., Illingworth, R. N., Critchley, J. A., & Proudfoot, A. T. (1980) · BMJ · doi:10.1136/bmj.280.6206.46-b · Cited by 626
Research works printed but not linked: 8
- Rogers, 2007, Respir Care, 52, 1176
- Pendyala, 1995, Cancer Epidemiol Biomarkers Prev, 4, 245
- Pierson, 2006, Respir Care, 51, 277
- Ng, 2008, Int J Neuropsychopharmacol, 1
- Spada, 2002, Clin Chem Lab Med, 40, 452
- 10.1002/1096-9071(200008)61:4<439::aid-jmv5>3.0.co;2-l · doi:10.1002/1096-9071(200008)61:4<439::aid-jmv5>3.0.co;2-l
- Caylak, 2008, Exp Toxicol Pathol
- Flora, 2007, Cell Mol Biol (Noisy-le-grand), 53, 26
Cited by
Berk, M., Kapczinski, F., Andreazza, A. C., Dean, O. M., Giorlando, F., Maes, M., Yücel, M., Gama, C. S., Dodd, S., Dean, B., et al. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.10.001 · Cited by 1,178
Self-citationMaes, M., Galecki, P., Chang, Y. S., & Berk, M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.05.004 · Cited by 1,140
Self-citationMoghaddam, B., & Javitt, D. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.181 · Cited by 1,035
The chemistry and biological activities of N-acetylcysteine
Samuni, Y., Goldstein, S., Dean, O. M., & Berk, M. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.04.016 · Cited by 876
Self-citationN-Acetylcysteine as an antioxidant and disulphide breaking agent: the reasons why
Aldini, G., Altomare, A., Baron, G., Vistoli, G., Carini, M., Borsani, L., & Sergio, F. (2018) · Free Radical Research · doi:10.1080/10715762.2018.1468564 · Cited by 830
Metadata
- Authors
- Dodd, S., Dean, O., Copolov, D. L., Malhi, G. S., & Berk, M.
- Affiliations
- Barwon Health (AU)
- Mental Health Research Institute (AU)
- The University of Sydney (AU)
- Venue
- Expert Opinion on Biological Therapy
- Publisher
- Informa UK Limited
- Published
- 2008-11-06
- Volume
- 8
- Issue
- 12
- Pages
- 1955-1962
- ISSN
- 1471-2598 (ISSN-L)
- 1744-7682
- OpenAlex
- W2170807824
- Cited by
- 413
- References
- 72
- Citations by year
- 2026: 8 · 2025: 18 · 2024: 27 · 2023: 22 · 2022: 26 · 2021: 35 · 2020: 32 · 2019: 17 · 2018: 22 · 2017: 26 · 2016: 22 · 2015: 26 · 2014: 24 · 2013: 27 · 2012: 25
- FWCI
- 17.23
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Expert Opinion on Biological Therapy (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Sulfur Compounds in Biology
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Keywords
- N-acetylcysteine, antioxidant therapy, glutathione, acetaminophen overdose, schizophrenia, bipolar disorder, mental illness, drug safety, tolerability, pharmacology
- MeSH terms
- Acetylcysteine, Antioxidants, Drug Administration Routes, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: N -acetylcysteine for antioxidant therapy: pharmacology and clinical utility. https://app.cochat.ai/papers/10.1517/14728220802517901
- The paper
- Dodd, S., Dean, O., Copolov, D. L., Malhi, G. S., & Berk, M. (2008). N -acetylcysteine for antioxidant therapy: pharmacology and clinical utility. Expert Opinion on Biological Therapy. https://doi.org/10.1517/14728220802517901
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.